Guanabenz and Clonidine, α2-Adrenergic Receptor Agonists, Inhibit Choroidal Neovascularization

CONCLUSION: Our study suggests a key role for α2-adrenergic receptors during CNV formation. Therefore, we suggest that α2-adrenergic receptor agonists may represent novel therapeutic drugs for patients with neovascular AMD.PMID:34011258 | DOI:10.2174/1567202618666210518133634

Source: Current Neurovascular Research - May 20, 2021 Category: Neurology Authors: Miruto Tanaka Yuki Inoue Takahiko Imai Norifumi Tanida Koichi Takahashi Hideaki Hara Source Type: research